Профилактика развития ЭРХПГ-ассоциированного панкреатита: руководство Европейского общества гастроинтестинальной эндоскопии в действующей редакции по состоянию на июнь 2014 года

1. Dumonceau J.M, Andriulli A, Devi re Jet al. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy 2010; 42: 503-515

2. Dumonceau J-M, Rigaux J, Kahaleh Met al. Prophylaxis of post-ERCPpancreatitis: a practice survey. Gastrointest Endosc 2010; 71: 934-939(e931-e932)

3. Kapral С, M hlberger A, Wewalka Fet al. Quality assessment of endoscopic retrograde cholangiopancreatography: results of a running nationwide Austrian benchmarking project after 5 years of implementation. Eur J Gastroenterol Hepatol 2012; 24: 1447-1454

4. Hanna M.S, Portal A.J, Dhanda AD et al. UK wide survey on the prevention of post-ERCP pancreatitis. Frontline Gastroenterol 2014; 5: 103-110

5. Cotton P.B, Lehman G, Vennes Jet al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991; 37: 383-393

6. Freeman M.L, Nelson D.B, Sherman Set al.Complications of endoscopicbiliary sphincterotomy. N Engl J Med 1996; 335: 909-918

7. Banks P.A, Bollen T.L, Dervenis Cet al. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62: 102-111

8. Artifon E.L, Chu A, Freeman Met al. A comparison of the consensus andclinical definitions of pancreatitis with a proposal to redefine post-endoscopic retrograde cholangiopancreatography pancreatitis. Pancreas 2010;39: 530-535

9. Dellinger E.P, Forsmark C.E, Layer Pet al. Determinant-based classification of acute pancreatitis severity: an international multidisciplinaryconsultation. Ann Surg 2012; 256: 875-880

10. Andriulli A.Loperfido S.Napolitano Get al. Incidence rates of post-ERCPcomplications: a systematic survey of prospective studies. Am J Gastroenterol 2007; 102: 1781-1788

11. Sutton V.R, Hong M.K, Thomas P.R. Using the 4-hour post-ERCP amylaselevel to predict post-ERCP pancreatitis. JOP 2011; 12: 372376

12. Williams E.J, Taylor S, Fairclough Pet al. Are we meeting the standardsset for endoscopy? Results of a large-scale prospective survey of endoscopic retrograde cholangio-pancreatograph practice Gut 2007; 56:821-829

13. Varadarajulu S, Kilgore M.L, Wilcox CM et al. Relationship among hospital ERCP volume, length of stay, and technical outcomes. GastrointestEndosc 2006; 64: 338-347

14. Allison M.C,Ramanaden D.N,Fouweather MG et al. Provision of ERCP services and training in the United Kingdom. Endoscopy 2000; 32:693-699

15. Hilsden R.J, Romagnuolo J, May G.R. Patterns of use of endoscopic retrograde cholangiopancreatography in a Canadian province. Can J Gastroenterol 2004; 18: 619-624

16. Loperfido S, Angelini G, Benedetti Get al. Major early complicationsfrom diagnostic and therapeutic ERCP: a prospective multicenterstudy. Gastrointest Endosc 1998; 48: 1-10

17. Williams E.J,Taylor S, Fairclough Petal. Risk factors for complication fol-lowing ERCP; results of a large-scale, prospective multicenter study.Endoscopy 2007; 39: 793-801

18. Swahn F, Nilsson M, Arnelo Uet al. Rendezvous cannulation techniquereduces post-ERCP pancreatitis: a prospective nationwide study of 12,718 ERCP procedures. Am J Gastroenterol 2013; 108: 552-559

19. Testoni P.A, Mariani A, Giussani Aet al. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study. Am J Gastroenterol2010; 105: 1753-1761

20. Masci E, Mariani A, Curioni Set al. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy 2003; 35: 830-834

21. Freeman ML,DiSario JA,Nelson DB et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001 ;54: 425-434

22. Masci E, Tot i G, Mariani Aet al.Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol2001; 96: 417-423

23. Harewood G.C, Pochron N.L, Gostout C.J. Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopicsnare excision of the duodenal ampulla. 'Gastrointest Endosc 2005; 62:367-370

24. Norton I.D, Gostout C.J, Baron THet al. Safety and outcome of endoscopicsnare excision of the major duodenal papilla. Gastrointest Endosc2002; 56: 239-243

25. Bailey A.A, Bourke M.J, Kaffes AJ et al. Needle-knife sphincterotomy: factors predicting its use and the relationship with post-ERCP pancreatitis(with video). Gastrointest Endosc 2010; 71: 266-271

26. Cotton R,Garrow D,Gallagher J et al. Risk factors for complications afterERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc 2009; 70: 80-88

27. Wilcox C.M, Phadnis M, Varadarajulu S. Biliary stent placement is associated with post-ERCP pancreatitis. Gastrointest Endosc 2010; 72:546-550

28. Swan M.R, Alexander S, Moss Aet al. Needle knife sphincterotomy doesnot increase the risk of pancreatitis in patients with difficult biliarycannulation. Clin Gastroenterol Hepatol 2013; 11: 430-436.e431

29. Meister T, Heinzow H, Heinecke Aet al. Post-ERCP pancreatitis in 2364ERCP procedures: is intraductal ultrasonography another risk factor?Endoscopy 2011; 43: 331-336

30. Gottlieb K, Sherman S, Pezzi Jet al. Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes. Am JGastroenterol 1996; 91: 1553-1557

31. Dai H.F, Wang X.W, Zhao K. Role of nonsteroidal anti-inflammatorydrugs in the prevention of post-ERCP pancreatitis: a meta-analysis.Hepatobiliary Pancreat Dis Int 2009; 8: 11-16

32. Elmunzer B, Waljee A, Elta Get al. A meta-analysis of rectal NSAIDs inthe prevention of post-ERCP pancreatitis. Gut 2008; 57: 1262

33. Zheng M-H,Xia H.Chen Y-P. Rectal administration of NSAIDs in the prevention of post-ERCP pancreatitis: a complementary metaanalysis.Gut 2008; 57: 1632

34. Elmunzer B.J.,Scheiman J.M,Lehman GA et al. A randomized trial of rectalindomethacin to prevent post-ERCP pancreatitis. N Engl J Med 2012,366: 1414-1422

35. Dobronte Z, Toldy E, Mark Let al. [Effects of rectal indomethacin in theprevention of post-ERCP acute pancreatitis]. Orv Hetil 2012; 153:990-996

36. Otsuka T, Kawazoe S, Nakashita S et al. Low-dose rectal diclofenac forprevention of post-endoscopic retrograde cholangiopancreatogra phypancreatitis: a randomized controlled trial. J Gastroenterol 2012; 47:912-917

37. Senol A, Saritas U, Demirkan H. Efficacy of intramuscular diclofenacand fluid replacement in prevention of post-ERCP pancreatitis. WorldJ Gastroenterol 2009; 15: 3999-4004

38. Bhatia V, Ahuja V, Acharya SK et al. A randomized controlled trial ofvaldecoxib and glyceryl trinitrate for the prevention of post-ERCP pancreatitis. J Clin Gastroenterol 2011; 45: 170-176

39. Ding X, Chen М, Huang Set al. Nonsteroidal anti-inflammatory drugsfor prevention of post-ERCP pancreatitis: a meta-analysis. GastrointestEndosc 2012; 76: 1152-1159

40. Yaghoobi M,Rolland S,Waschke KA et al. Meta-analysis: rectal ' indomethacin for the prevention of post-ERCP pancreatitis. Aliment Pharmacol Ther 2013; 38: 995-1001

41. Sun H.L, Han B, Zhai HP et al. Rectal NSAIDs for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trials.Surgeon 2014; 12: 141-147

42. Yuhara H, Ogawa M, Kawaguchi Yet al. Pharmacologic prophylaxis ofpostendoscopic retrograde cholangiopancreatography pancreatitis:protease inhibitors and NSAIDs in a meta-analysis. J Gastroenterol2014; 49: 388-399

43. Sethi S, Sethi N, Wadhwa Vet al. A meta-analysis on the role of rectaldiclofenac and indomethacin in the prevention of post-endoscopicretrograde cholangiopancreatography pancreatitis. Pancreas 2014;43: 190-197

44. Elmunzer BJ, Higgins PD, Saini SD et al. Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patientsundergoing high-risk ERCP? Post hoc efficacy and cost-benefit analy-ses using prospective clinical trial data Am J Gastroenterol 2013; 108:410-415

45. Zhang Y, Chen Q.B, Gao ZY et al. Meta-analysis: octreotide preventspost-ERCP pancreatitis, but only at sufficient doses. Aliment Pharmacol Ther 2009; 29: 1155-1164

46. mata F, Deshpande G.Tokuda Yetal. Meta-analysis: somatostatin orits long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis. J Gastroenterol 2010; 45: 885-895

47. Katsinelos P, Fasoulas K, Paroutoglou Get al.Combination of diclofenacplus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial. Endoscopy 2012; 44:53-59

48. Wang ZK,Yang YS,Cai FC et al.lsprophylacticsomatostatineffective toprevent post-endoscopic retrograde cholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilottrial Chin Med J (Engl) 2013; 126: 2403-2408

49. Andriulli A, Clemente R, Solmi Let al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gas-trointest Endosc 2002; 56: 488-495

50. Andriulli A, Solmi L, Loperfido Set al. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexatemesylate. Clin Gastroenterol Hepatol 2004; 2: 713-718

51. Benvenutti S, Zancanella L, Piazzi Let al. Prevention of post-ERCP pancreatitis with somatostatin versus gabexate mesylate: A randomizedplacebo controlled multicenter study. Dig Liv Dis 2006; 38: S15

52. Cavallini G, Tittobello A, Frulloni Let al. Gabexate for the prevention ofpancreatic damage related to endoscopic retrograde cholangiopan-creatography. Gabexate in digestive endoscopy -Italian Group. N EnglJ Med 1996; 335: 919-923

53. Manes G, Ardizzone S, Lombardi Get al. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study. GastrointestEndosc 2007; 65: 982-987

54. Xiong G.S, Wu S.M, Zhang XW et al. Clinical trial of gabexate in the praphylaxis of post-endoscopic retrograde cholangiopancreatograp hypancreatitis. Braz J Med Biol Res 2006; 39: 85-90

55. Fujishiro H, Adachi K, Imaoka T et al. Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study. J , Gastroenter-ol Hepatol 2006; 21: 1065-1069

56. Yoo JW, Ryu JK, Lee SH et al. Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis inhigh-risk patients: a prospective, randomized, placebo-controlledtrial. Pancreas 2008; 37: 366-370

57. Tsujino T, Komatsu Y, Isayama Het al. Ulinastatin for pancreatitis afterendoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Clin Gastroenterol Hepatol 2005' 3376-383

58. Ueki T.Otani K,Kawamoto Ket al.Comparison between ulinastatin andgabexate mesylate for the prevention of post-endoscopic re trogradecholangiopancreatography pancreatitis: a prospective, randomizedtrial. J Gastroenterol 2007; 42: 161-167

59. Chen S, Shi H, Zou Xet al. Role of ulinastatin in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: the Emperor’s New Clothes or Aladdin's Magic Lamp? Pancreas 2010; 39:1231-1237

60. Seta T, Noguchi Y. Protease inhibitors for preventing complicationsassociated with ERCP: an updated meta-analysis. Gastrointest Endosc2011; 73: 700-706 (e1-e2)

61. Zhang ZF, Yang N, Zhao Get al. Preventive effect of ulinastatin and gabexate mesylate on post-endoscopic retrograde cholangiopancreatography pancreatitis. Chin Med J (Engl) 2010; 123: 2600-2606

62. Choi C.W, Kang D.H, Kim GH et al. Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis. Gastrointest Endosc 2009; 69: e11-e18

63. Park K.T, Kang D.H, Choi CW et al. Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients? Pancreas 2011; 40: 1215-1219

64. Yoo K.S, Huh K.R, Kim YJet al. Nafamostat mesilate for prevention ofpost-endoscopic retrograde cholangiopancreatography pancreatitis: aprospective, randomized, double-blind, controlled trial. Pancreas2011; 40: 181-186

65. Shao L, Chen Q, Chen Met al. Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis. Dig Dis Sci 2010; 55: 1-7

66. Bang UC, Njgaard C, Andersen PK et al. Meta-analysis: nitroglycerin forprevention of post-ERCP pancreatitis. Aliment Pharmacol Ther 2009;29: 1078-1085

67. Gorelick A, Barnett J, Chey Wet al. Botulinum toxin injection after biliary sphincterotomy. Endoscopy 2004; 36: 170-173

68. Matsushita M, Takakuwa H, Shimeno Net al. Epinephrine sprayed onthe papilla for prevention of post-ERCP pancreatitis. J Gastroenterol2009; 44: 71-75

69. Schwartz J.J, Lew R.J, Ahmad NA et al. The effect of lidocaine sprayed onthe major duodenal papilla on the frequency of post-ERCP pancreatitis.Gastrointest Endosc 2004; 59: 179-184

70. Prat F, Amaris J, Ducot Bet al. Nifedipine for prevention of post-ERCPpancreatitis: a prospective, double-blind randomized study. Gastrointest Endosc 2002; 56: 202-208

71. Sand J, Nordback I. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangio-pancreatography. Digestion 1993; 54: 105-111

72. Bai Y, Xu C, Yang Xet al. Glyceryl trinitrate for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a meta-analysis of randomized, double-blind, placebo-controlled trials. Endos-copy 2009; 41: 690-695

73. Ding J, Jin X, Pan Yet al. Glyceryl trinitrate for prevention of post-ERCPpancreatitis and improve the rate of cannulation: a metaanalysis of prospective, randomized, controlled trials. PloS One 2013, 8:e75645

74. Xu L.H, Qian J.B, Gu LG et al. Prevention of post-endoscopic retro gradecholangiopancreatography pancreatitis by epinephrine sprayed onthe papilla. J Gastroenterol Hepatol 2011; 26: 1139-1144

75. Akshintala V.S, Hutfless S.M, Colantuoni Eet al. Systematic review withnetwork meta-analysis: pharmacological prophylaxis against post-ERCP pancreatitis. Aliment Pharmacol Ther 2013; 38: 1325- 1337

76. Rty S, Sand J, Pulkkinen Met al. Post-ERCP pancreatitis: reduction byroutine antibiotics. J Gastrointest Surg 2001; 5: 339-345 (discussion345)

77. Wollschlger S, Ptzold K, Bulang Tet al. [Effect of preventive seleniumadministration on development of ERCP-induced acute pancreatitis].Med Klin (Munich) 1999; 94: 0381-83

78. Niederau C, Pohlmann U, Lbke Het al. Prophylactic antibiotic treatment in therapeutic or complicated diagnostic ERCP: results of a randomized controlled clinical study. Gastrointest Endosc 1994; 40:533-537

79. Alveyn C.G, Robertson D.A, Wright Ret al. Prevention of sepsis followingendoscopic retrograde cholangiopancreatography. J Hosp Infect 1991; 19: Suppl С 65-70

80. Buxbaum J, Yan A, Yeh Ket al. Aggressive hydration with lactated ringer’s solution reduces pancreatitis after endoscopic retrograde cholan-giopancreatography. Clin Gastroenterol Hepatol 2014; 12: 303-307(e301)

81. Sagi S.V, Schmidt S, Fogel Eet al. Association of greater intravenous volume infusion with shorter hospitalization for patients with post-ERCPpancreatitis. J Gastroenterol Hepatol 2014; 29: 1316-1320

82. DiMagno MJ, Wamsteker E-J, Maratt J et al. Do larger periproceduralfluid volumes reduce the severity of post-endoscopic retrograde cholangiopancreatography pancreatitis? Pancreas 2014; 43:642-647

83. Bai Y, Gao J, Shi Xet al. Prophylactic corticosteroids do not preventpost-ERCP pancreatitis: a meta-analysis of randomized controlledtrials. Pancreatology 2008; 8: 504-509

84. Zheng M, Bai J, Yuan Bet al. Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis. BMC Gastroenterol 2008; 8: 6 DO110.1186/1471-230X-8-6

85. Sherman S, Cheng C-L, Costamagna Get al. Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk.Pancreas 2009; 38: 267-274

86. Dumot J.A, Conwell D.L, Zuccaro Get al. A randomized, double blindstudy of interleukin 10 for the prevention of ERCP-induced pancreatitis. Am J Gastroenterol 2001; 96: 2098-2102

87. Devi re J, Le Moine O, Van Laethem JL et al.Interleukin 10 reduces theincidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001; 120: 498-505

88. Barkay O, Niv E, Santo Eet al. Low-dose heparin forthe prevention ofpost-ERCP pancreatitis: a randomized placebo-controlled trial. SurgEndosc 2008; 22: 1971-1976

89. Rabenstein T,Fischer B.Wiessner Vet al. Low-molecular-weight heparindoes not prevent acute post-ERCP pancreatitis. Gastrointest Endosc2004; 59: 606-613

90. Schwartz J.J, Lew R.J, Ahmad NAet al. The effect of lidocaine sprayed onthe major duodenal papilla on the frequency of post-ERCP pancreatitis.Gastrointest Endosc 2004; 59: 179-184

91. Prat F, Amaris J, Ducot Bet al. Nifedipine for prevention of post-ERCPpancreatitis: a prospective, double-blind randomized study. Gastrointest Endosc 2002; 56: 202-208

92. Sand J, Nordback I. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangio-pancreatography. Digestion 1993; 54: 105-111

93. Andriulli A, Annese V. Risk of post-endoscopic retrograde cholangio-pancreatography pancreatitis and ways to prevent it: old myths, a current need? The case of allopurinol Clin Gastroenterol Hepatol 2008; 6:374-376

94. Bai Y.Gao J,Zhang Wet al. Meta-analysis: allopurinol in the preventionof postendoscopic retrograde cholangiopancreatography pancreatitis.Aliment Pharmacol Ther 2008; 28: 557-564

95. Katsinelos P.Kountouras J.Paroutoglou Get al.- Intravenous N-acetylcysteine does not prevent post-ERCP pancreatitis. Gastrointest Endosc2005; 62: 105-111

96. Lavy A, Karban A, Suissa Aet al. Natural beta-carotene for the prevention of post-ERCP pancreatitis. Pancreas 2004; 29: e45-e50

97. Milewski J, Rydzewska G, Degowska M et al. N-acetylcysteinedoes notprevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis. World J Gastroenterol 2006; 12: 3751-3755

98. Zheng M, Chen Y, Bai Jet al. Meta-analysis of prophylactic allopurinoluse in post-endoscopic retrograde cholangiopancreatography pancreatitis. Pancreas 2008; 37: 247-253

99. Li S, Cao G, Chen Xet al. Low-dose heparin in the prevention of postendoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2012;24: 477-481

100. Gu W-J, Wei C-Y, Yin R-X. Antioxidant supplementation forthe prevention of post-endoscopic retrograde cholangiopancreatograp hypancreatitis: a meta-analysis of randomized controlled trials. Nutr J2013;12: 23

101. Abbasinazari M, Mohammad Alizadeh AH, Moshiri K et al. Does allopurinol prevent post endoscopic retrograde cholangio-pancreato-graphy pancreatitis? A randomized double blind trial Acta Med Iran2011; 49: 579-583

102. Andriulli A, Forlano R, Napolitano Get al. Pancreatic duct stents in theprophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systematic analysis of benefits and associated risks. Digestion 2007; 75: 156-163

103. Singh P, Das A, Isenberg G et al. Does prophylactic pancreatic stentplacement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials Gastrointest Endosc 2004; 60: 544-550

104. Sofuni A.Maguchi H.ltoi Tet al. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent. Clin Gastroenterol Hepatol2007; 5: 1339-1346

105. Das A, Singh P, Sivak MV et al. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest Endosc 2007; 65: 960-968

106. Mazaki T, Mado K, Masuda Het al. Prophylactic pancreatic stentplacement and post-ERCP pancreatitis: an updated metaanalysis. JGastroenterol 2014; 49: 343-355

107. Akbar A, Abu Dayyeh B.K, Baron TH et al. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis. Clin Gastroenterol Hepatol 2013; 11:778-783

108. Afghani E, Akshintala VS, Khashab MA et al. 5-Fr vs 3-Fr pancreaticstents for the prevention of post-ERCP pancreatitis in high-risk patients: a systematic review and network meta-analysis Endoscopy2014; 46: 173-80

109. Chahal Р, Tarnasky PR, Petersen BT et al. Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholan-giopancreatography pancreatitis. Clin Gastroenterol Hepatol 2009; 7:834-839

110. Zolotarevsky E, Fehmi SM, Anderson MA et al. Prophylactic 5-Fr pancreatic duct stents are superior to 3-Fr stents: a randomized controlled trial. Endoscopy 2011; 43: 325-330

111. Cha S.W, Leung W.D, Lehman GAet al. Does leaving a main pancreaticduct stent in place reduce the incidence of precut biliary sphincterotomy-associated pancreatitis? A randomized, prospective study Gastrointest Endosc 2013; 77: 209-216

112. Moffatt DC, Pradermchai K, Avula H et al. Moderate and severe post-endoscopic retrograde cholangiopancreatography pancreatitis despite prophylactic pancreatic stent placement: the effect of early pro-phylactic pancreatic stent dislodgement. Can J Gastroenterol 2011 ;25: 215-219

113. Rashdan A, Fogel EL, McHenry L et al. Improved stent characteristicsfor prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol2004; 2: 322-329

114. Price L.H, Brandabur J.J, Kozarek RAetal. Good stents gone bad: endoscopic treatment of proximally migrated pancreatic duct stents. Gastrointest Endosc 2009; 70: 174-179

115. Halttunen J, Meisner S, Aabakken Let al. Difficult cannulation as defined by a prospective study of the Scandinavian Association for Digestive Endoscopy (SADE) in 907 ERCPs. Scand J Gastroenterol 2014;49: 752-758

116. Wang P, Li Z-S, Liu Fet al. Risk factors for ERCP-related complications prospective multicenter study. Am J Gastroenterol 2009; 104: 31-40

117. Wang B, Guo Z, Liu Zet al. Preoperative versus intraoperative endoscopic sphincterotomy in patients with gallbladder and suspectedcommon bile duct stones: system review and metaanalysis. Surg En-dosc 2013;27: 2454-2465

118. Cheon Y.K, Cho K.B, Watkins JL et al. Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification. Gastrointest Endosc 2007; 65: 385-393

119. George S, Kulkarni A.A, Stevens Get al. Role of osmolality of contrastmedia in the development of post-ERCP pancreatitis: a metanalysis.Dig Dis Sci 2004; 49: 503-508

120. Ogawa M, Kawaguchi Y, Kawashima Yet al. A comparison of ionic,monomer, high osmolar contrast media with non-ionic, dimer, iso-osmolar contrast media in ERCP. Tokai J Exp Clin Med 2013; 38:109-1 13

121. Cheng Y, Xiong X-Z, Wu S-Jet al. Carbon dioxide insufflation for endoscopic retrograde cholangiopancreatography: A meta-analysis andsystematic review. World J Gastroenterol 2012; 18: 5622-5631

122. Shi H, Chen S, Swar Get al. Carbon dioxide insufflation during endoscopic retrograde cholangiopancreatography: a review and meta-analysis. Pancreas 2013; 42: 1093-1100

123. Wu J, Hu B. Carbon dioxide insufflation versus air insufflation duringendoscopic retrograde cholangiopancreatography: a metaanalysis. Jlnterv Gastroenterol 2013; 3: 37-42

124. Janssens F, Deviere J, Eisendrath Pet al. Carbon dioxide for gut distension during digestive endoscopy: technique and practice survey.World J Gastroenterol 2009; 15: 1475-1479

125. Cennamo V, Fuccio L, Zagari RM et al. Can a wire-guided cannulationtechnique increase bile duct cannulation rate and prevent post-ERCPpancreatitis? A meta-analysis of randomized controlled trials Am JGastroenterol 2009; 104: 2343-2350

126. Cheung J.Tsoi KK.Quan W-Let al. Guidewire versus conventional contrast cannulation of the common bile duct for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Gastrointest Endosc 2009; 70: 1211-1219

127. Lee T.H, Park D.H, Park J-Yet al. Can wire-guided cannulation preventpost-ERCP pancreatitis? A prospective randomized trial GastrointestEndosc 2009; 69: 444-449

128. Kawakami H, Maguchi H, Mukai Tet al. A multicenter, prospective,randomized study of selective bile duct cannulation performed bymultiple endoscopists: the BIDMEN study. Gastrointest Endosc2012; 75: 362-372(e361)

129. Mariani A, Giussani A, Di Leo Met al. Guidewire biliary cannulationdoes not reduce post-ERCP pancreatitis compared with the contrastinjection technique in low-risk and high-risk patients. GastrointestEndosc 2012; 75: 339-346

130. Mohammad Alizadeh AH, Afzali ES, Zafar Doagoo S et al. Preventiverole of wire-guided cannulation to reduce hyperamylasemia andpancreatitisfollowing endoscopic retrograde cholangiopancreatography. Diagn Ther Endosc 2012; 2012: 821376

131. Kobayashi G, Fujita N, Imaizumi Ket al. Wire-guided biliary cannulation technique does not reduce the risk of post-ERCP pancreatitis:multicenter randomized controlled trial. Dig Endosc 2013; 25: 295-302

132. Tse F, Yuan Y, Moayyedi Pet al. Guide wire-assisted cannulation forthe prevention of post-ERCP pancreatitis: a systematic review andmeta-analysis. Endoscopy 2013; 45: 605-618

133. Rey JF, Beilenhoff U, Neumann CS et al. European Society of Gastrointest Endosc (ESGE) guideline: the use of electrosurgical units. Endoscopy 2010; 42: 764-772

134. Verma D, Kapadia A, Adler D.G. Pure versus mixed electrosurgical current for endoscopic biliary sphincterotomy: a meta-analysis of adverse outcomes. Gastrointest Endosc 2007; 66: 283-290

135. Dumonceau J-M, Deviere J, Cremer M. A new method of achievingdeep cannulation of the common bile duct during endoscopic retrograde cholangiopancreatography. Endoscopy 1998; 30: S80

136. Gy keres T, Duhl J, Vars nyi Met al. Double guide wire placement forendoscopic pancreaticobiliary procedures. Endoscopy 2003; 35: 95-96

137. Maeda S, Hayashi H, Hosokawa Oetal. Prospective randomized pilottrial of selective biliary cannulation using pancreatic guide-wireplacement. Endoscopy 2003; 35: 721-724

138. Herreras de Tejada A, Calleja JL, Diaz G et al. Double-guidewire technique for difficult bile duct cannulation: a multicenter randomized,controlled trial. Gastrointest Endosc 2009; 70: 700-709

139. Xinopoulos D, Bassioukas SP, Kypreos Det al. Pancreatic duct guide-wire placement for biliary cannulation in a single-session therapeuticERCP. World J Gastroenterol 2011; 17: 1989-1995

140. Gr nroos J.M, Vihervaara H, Gullichsen Ret al. Double-guidewire-assisted biliary cannulation: experiences from a single tertiary referralcenter. Surg Endosc 2011; 25: 1599-1602

141. Belverde B, Frattaroli S, Carbone Aet al. Double guidewire techniquefor ERCP in difficult bile cannulation: experience with 121 cases.Ann Ital Chir 2012; 83: 391-393

142. Angsuwatcharakon P, Rerknimitr R, Ridtitid Wet al. Success rate andcannulation time between precut sphincterotomy and double-guide-wire technique in truly difficult biliary cannulation. J GastroenterolHepatol 2012; 27: 356-361

143. Yoo YW, Cha S-W, Lee WC et al. Double guidewire technique vs transpancreatic precut sphincterotomy in difficult biliary cannulation. World J Gastroenterol 2013; 19: 108-114

144. Ito K, Horaguchi J, Fujita Net al. Clinical usefulness of double-guide-wire technique for difficult biliary cannulation in endoscopic retrograde cholangiopancreatography. Dig Endosc 2014; 26: 442449 '

145. Tanaka R, Itoi T, Sofuni Aet al. Is the double-guidewire technique superior to the pancreatic duct guidewire technique in cases of pancreatic duct opacification? J Gastroenterol Hepatol 2013; 28: 1787-1793

146. Ito K,Fujita N.Noda Yet al. Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewireplacement for achieving selective biliary cannulation? A prospectiverandomized controlled trial J Gastroenterol 2010; 45: 1183-1191

147. Hisa T. Impact of changing our cannulation method on the incidenceof post-endoscopic retrograde cholangiopancreatography pancreatitis after pancreatic guidewire placement. World J Gastroenterol2011; 17: 5289

148. Cennamo V, Fuccio L, Zagari RM et al.Canearlyprecutimplementation reduce endoscopic retrograde cholangiopancreatography-related complication risk? Meta-analysis of randomized controlled trialsEndoscopy 2010; 42: 381 -388

149. Gong B.Hao L.Bie Let al. Does precut technique improve selective bileduct cannulation or increase post-ERCP pancreatitis rate? A meta-analysis of randomized controlled trials Surg Endosc 2010; 24: 2670-2680

150. Katsinelos R,Gkagkalis S., Chatzimavroudis G et al.Comparison of threetypes of precut technique to achieve common bile duct cannulation:a retrospective analysis of 274 cases. Dig Dis Sci 2012; 57:3286-3292

151. Lopes L, Dinis-Ribeiro M, Rolanda C. Safety and efficacy of precut needle-knife fistulotomy. Scand J Gastroenterol 2014; 49: 759-765

152. Chan CHY, Brennan FN, Zimmerman MJ et al. Wire assisted transpan-creatic septotomy, needle knife precut or both for difficult biliary access. J Gastroenterol Hepatol 2012; 27: 1293-1297

153. Wang P, Zhang W, Liu Fet al. Success and complication rates of twoprecut techniques, transpancreatic sphincterotomy and needle-knifesphincterotomy for bile duct cannulation. J Gastrointest Surg 2010; 14: 697-704

154. Yasuda I, Tomita E, Enya Met al. Can endoscopic papillary balloon dilation really preserve sphincter of Oddi function? Gut 2001; 49:686-691

155. Baron TH, Harewood GC. Endoscopic balloon dilation of the biliarysphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a metaanalysis of randomized, controlled trials. Am J Gastroenterol 2004; 99: 14551460

156. Weinberg BM, Shindy W, Lo S. Endoscopic balloon sphincter dilation(sphincteroplasty) versus sphincterotomy for common bile ductstones. Cochrane Database Syst Rev 2006; 18: CD004890

157. Liu Y, Su P, Lin Set al. Endoscopic papillary balloon dilatation versusendoscopic sphincterotomy in the treatment for choledocholithiasis:a meta-analysis. J Gastroenterol Hepatol 2012; 27:464-471

158. Liao W-C, Tu Y-K, Wu М-Set al. Balloon dilation with adequate duration is safer than sphincterotomy for extracting bile duct stones: asystematic review and meta-analyses. Clin Gastroenterol Hepatol2012; 10: 1101-1109

159. Liao W-C,Lee C-T,Chang С-Yet al. Randomized trial of 1 -minute versus5minute endoscopic balloon dilation for extraction of bile ductstones. Gastrointest Endosc 2010; 72: 1154-1162

160. Zhao H-C. Meta-analysis comparison of endoscopic papillary balloondilatation and endoscopic sphincteropapillotomy. World J Gastroenterol 2013; 19: 3883-3891

161. Natsui M, Saito Y.Abe Set al. Long-term outcomes of endoscopic papillary balloon dilation and endoscopic sphincterotomy for bile ductstones. Dig Endosc 2013; 25: 313-321

162. Doi S, Yasuda I, Mukai Tet al.Comparison of long-term outcomesafter endoscopic sphincterotomy versus endoscopic papillary balloondilation: a propensity score-based cohort analysis. J Gastroenterol2012; 48: 1090-1096

163. Ersoz G, Tekesin O, Ozutemiz AO et al. Biliary sphincterotomy plus dilation with a large balloon for bile duct stones that are difficult to extract. Gastrointest Endosc 2003; 57: 156-159

164. Attasaranya S, Cheon Y.K, Vittal Het al. Large-diameter biliary orificeballoon dilation to aid in endoscopic bile duct stone removal: a multi-center series. Gastrointest Endosc 2008; 67: 1046-1052

165. Maydeo A.Bhandari S. Balloon sphincteroplasty for removing difficultbile duct stones. Endoscopy 2007; 39: 958-961

166. Minami A, Hirose S, Nomoto Tet al. Small sphincterotomy combinedwith papillary dilation with large balloon permits retrieval of largestones without mechanical lithotripsy. World J Gastroenterol 2007; 13: 2179-2182

167. Misra SP, Dwivedi M. Large-diameter balloon dilation after endoscopic sphincterotomy for removal of difficult bile duct stones. Endoscopy 2008;40: 209-213

168. Heo J.H.Kang DH.Jung HJ et al. Endoscopic sphincterotomy plus large-balloon dilation versus endoscopic sphincterotomy for removal ofbileduct stones. Gastrointest Endosc 2007; 66: 720-726 ; quiz 768,771

169. Feng Y, Zhu H, Chen Xet al.Comparison of endoscopic papillary largeballoon dilation and endoscopic sphincterotomy for retrieval of choledocholithiasis: a meta-analysis of randomized controlled trials. JGastroenterol 2012; 47: 655-663

170. Kim T.H, Oh H.J, Lee JY et al. Can a small endoscopic sphincterotomyplus a large-balloon dilation reduce the use of mechanical lithotripsyin patients with large bile duct stones? Surg Endosc 2011;25: 3330-3337

171. Liu Y, Su P, Lin Yet al. Endoscopic sphincterotomy plus balloon dilation versus endoscopic sphincterotomy for choledocholithiasis: Ameta-analysis. J Gastroenterol Hepatol 2013; 28: 937-945

172. Madhoun MF, Wani S, Hong Set al. Endoscopic papillary large balloondilation reduces the need for mechanical lithotripsy in patients withlarge bile duct stones: a systematic review and meta-analysis. DiagnTher Endosc 2014; 2014: 1-8

173. Singh P, Gurudu S.R, Davidoff Set al. Sphincter of Oddi manometrydoes not predispose to post-ERCP acute pancreatitis. Gastrointest Endosc 2004; 59: 499-505

174. Sherman S,Hawes R.H.Troiano FP et al. Pancreatitis following bile ductsphincter of Oddi manometry: utility of the aspirating catheter. Gastrointest Endosc 1992; 38: 347-350

175. Pfau P.R.Banerjee S,Barth BA et al. Sphincter of Oddi manometry. Gastrointest Endosc 2011; 74: 1175-1180

176. Saad A.M, Fogel E.L, McHenry Let al. Pancreatic duct stent placementprevents post-ERCP pancreatitis in patients with suspected sphincterof Oddi dysfunction but normal manometry results. Gastrointest Endosc 2008; 67: 255-261

177. Kaffes A.J, Sriram P.VJ, Rao GV et al. Early institution of precutting fordifficult biliary cannulation: a prospective study comparing conventional vs. a modified technique. Gastrointest Endosc 2005; 62: 669-674